HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by KBC Group NV

KBC Group NV trimmed its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 14.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 378,488 shares of the company’s stock after selling 63,326 shares during the quarter. KBC Group NV’s holdings in HCA Healthcare were worth $153,829,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Plato Investment Management Ltd raised its holdings in shares of HCA Healthcare by 51.6% during the 3rd quarter. Plato Investment Management Ltd now owns 4,770 shares of the company’s stock worth $1,937,000 after acquiring an additional 1,624 shares during the period. OVERSEA CHINESE BANKING Corp Ltd boosted its holdings in HCA Healthcare by 23.2% in the 3rd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 2,923 shares of the company’s stock valued at $1,188,000 after purchasing an additional 550 shares during the last quarter. GSA Capital Partners LLP acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth approximately $567,000. Waverton Investment Management Ltd increased its stake in HCA Healthcare by 12.7% during the third quarter. Waverton Investment Management Ltd now owns 159,382 shares of the company’s stock worth $64,767,000 after acquiring an additional 17,968 shares during the last quarter. Finally, Nations Financial Group Inc. IA ADV acquired a new stake in shares of HCA Healthcare during the 3rd quarter worth about $325,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. Wells Fargo & Company lifted their target price on shares of HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a report on Wednesday, November 6th. Truist Financial boosted their price target on shares of HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, August 19th. Leerink Partners increased their target price on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a report on Wednesday, July 24th. Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Finally, TD Cowen dropped their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating on the stock in a research note on Monday, October 28th. Five equities research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Stock Performance

Shares of HCA opened at $349.32 on Thursday. The stock has a market cap of $88.48 billion, a P/E ratio of 15.69, a PEG ratio of 1.35 and a beta of 1.68. The company has a current ratio of 1.12, a quick ratio of 1.00 and a debt-to-equity ratio of 48.71. The company has a 50-day moving average of $387.95 and a two-hundred day moving average of $357.16. HCA Healthcare, Inc. has a 12-month low of $233.23 and a 12-month high of $417.14.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Friday, December 13th will be paid a $0.66 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.76%. HCA Healthcare’s payout ratio is currently 11.85%.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The stock was sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 1.60% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.